(Q45281367)

11 December 2017

PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity (English)

1 reference

11 December 2017

5

1 reference

11 December 2017

4

Peter Bartenstein

1 reference

11 December 2017

6

Paul Cumming

1 reference

11 December 2017

2

Ingo Vernaleken

1 reference

11 December 2017

1

Yoshitaka Kumakura

1 reference

11 December 2017

Gerhard Gründer

3

1 reference

11 December 2017

1 July 2005

1 reference

Journal of Cerebral Blood Flow & Metabolism

11 December 2017

1 reference

11 December 2017

25

1 reference

11 December 2017

7

1 reference

11 December 2017

807-819

1 reference

Positron emission tomography suggests that the rate of progression of idiopathic parkinsonism is slow

11 December 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Apomorphine test for dopaminergic responsiveness: a dose assessment study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Determination of plasma [18F]-6-fluorodopa during positron emission tomography: elimination and metabolism in carbidopa treated subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Ageing of substantia nigra in humans: cell loss may be compensated by hypertrophy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Design and construction of a realistic digital brain phantom

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

The metabolism of [18F]6-fluoro-L-3,4-dihydroxyphenylalanine in the hooded rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Altered metabolism of [18F]-6-fluorodopa in the hooded rat following inhibition of catechol-O-methyltransferase with U-0521.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Kinetics of in vitro decarboxylation and the in vivo metabolism of 2-18F- and 6-18F-fluorodopa in the hooded rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

A kinetic analysis of 6-[18F]fluoro-L-dihydroxyphenylalanine metabolism in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Regulation of DOPA decarboxylase activity in brain of living rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Cerebral dopamine concentrations during levodopa treatment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Loss of metabolites from monkey striatum during PET with FDOPA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Cerebral 6-[(18)F]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

On the accuracy of an [18F]FDOPA compartmental model: evidence for vesicular storage of [18F]fluorodopamine in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Effects of catechol-O-methyltransferase inhibition on the rates of uptake and reversibility of 6-fluoro-L-Dopa trapping in MPTP-induced parkinsonism in monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Time profile of cerebral [18F]6-fluoro-L-DOPA metabolites in nonhuman primate: implications for the kinetics of therapeutic L-DOPA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Dopamine visualized in the basal ganglia of living man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Kinetics of the metabolism of four PET radioligands in living minipigs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

High‐ and Low‐Affinity Transport of D‐Glucose from Blood to Brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Calculation of cerebral glucose phosphorylation from brain uptake of glucose analogs in vivo: a re-examination.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Dopa decarboxylase activity of the living human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Striatal L-dopa decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Positron emission tomography in drug evaluation: influence of three different catechol-O-methyltransferase inhibitors on metabolism of [NCA] 6-[18F]fluoro-L-dopa in rhesus monkey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

The cerebral metabolism of L-dihydroxyphenylalanine. An autoradiographic and biochemical study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

6-[18F]fluoro-L-dopa metabolism in living human brain: a comparison of six analytical methods.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Michaelis-Menten constraints improved cerebral glucose metabolism and regional lumped constant measurements with [18F]fluorodeoxyglucose.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Effect of catechol-O-methyltransferase inhibition on brain uptake of [18F]fluorodopa: implications for compartmental modelling and clinical usefulness.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Nigrostriatal function in humans studied with positron emission tomography

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Aging and Extrapyramidal Function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Cerebral 6-[18F]fluoro-L-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Striatal [18F]fluorodopa utilization after COMT inhibition with entacapone studied with PET in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in Lytico-Bodig. The amyotrophic lateral sclerosis-parkinsonism-dementia complex of Guam

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

A reversible tracer analysis approach to the study of effective dopamine turnover

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Increase in dopamine turnover occurs early in Parkinson's disease: evidence from a new modeling approach to PET 18 F-fluorodopa data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: their relation to disease-compensatory mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

In vivo measurement of the vesicular monoamine transporter in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

The distribution and kinetics of [18F]6-fluoro-3-O-methyl-L-dopa in the human brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Rapid Automated Algorithm for Aligning and Reslicing PET Images

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Blood-brain barrier and neuronal membrane transport of 6-[18F]fluoro-L-DOPA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JCBFM.9600079

7 January 2021

Identifiers

DOI

10.1038/SJ.JCBFM.9600079

1 reference

11 December 2017

1 reference

PubMed ID

15729292